Microbiotix, Inc. Company Profile

08:52 EDT 17th March 2018 | BioPortfolio

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company currently has four novel compound series in research and development. Microbiotix currently has in development MBX 500, the first antibiotic that targets the DNA polymerase of Gram-positive bacteria, including drug resistant strains. Microbiotix has an active research program to discover a broad-spectrum antibiotic that targets DNA replication of drug-resistant Gram-positive and Gram-negative bacteria. In addition to a Gram-positive antibiotic (MBX500), Microbiotix's most advanced antiviral compounds are for the treatment of respiratory syncytial virus (RSV) (MBX 300) and cytomegalovirus (CMV) (MBX400) which are in preclinical development.
Microbiotix has an active biodefense program, focused on novel therapeutics for Bacillus Anthraocis and Burkholderia pseudomalli, Microbiotix is also actively involved in the discovery of inhibitors of bacterial biofilm formation and antibiotic resistance.


One Innovation Drive
United States of America


Phone: (508) 757-2800
Fax: (508) 757-1999

News Articles [3 Associated News Articles listed on BioPortfolio]

Microbiotix partners with AMR Centre to develop bacterial virulence inhibitor

Microbiotix and the AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients

Microbiotix, Inc., a clinical stage biotech company focused on the discovery and development of novel drugs that target serious infectious diseases, and the AMR Centre, a joint private-public initiati...

Global Swine and Avian Influenza Drug Development Pipeline Review 2017 Featuring Gemmus Pharma, Aphios, Fides Pharma, Inovio, Microbiotix, NanoViricides, Shionogi and Tria Bioscience

DUBLIN, Feb. 6, 2018 /PRNewswire/ -- The "Swine and Avian Influenza Drug Development Pipeline Review, 2017" report has been added to's offering. H5N1 is a type of influenza ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Microbiotix, Inc.

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially signifi...

Microbiotix Incorporated

MICROBIOTIX is an emerging biotechnology/pharmaceutical company currently engaged in research and development of novel anti-infective drugs. The company maintains its corporate offices and research la...

More Information about "Microbiotix, Inc." on BioPortfolio

We have published hundreds of Microbiotix, Inc. news stories on BioPortfolio along with dozens of Microbiotix, Inc. Clinical Trials and PubMed Articles about Microbiotix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Microbiotix, Inc. Companies in our database. You can also find out about relevant Microbiotix, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record